The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     
 


Published online June 17, 2009
The Journal of Immunology, 2009, doi:10.4049/jimmunol.0802047
Copyright © 2009 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jimmunol.0802047v1
183/1/51    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Liu, X. S.
Right arrow Articles by Frazer, I. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, X. S.
Right arrow Articles by Frazer, I. H.

IFN-{gamma} Promotes Generation of IL-10 Secreting CD4+ T Cells that Suppress Generation of CD8 Responses in an Antigen-Experienced Host

Xiao Song Liu*, Joanne Leerberg*, Kelli MacDonald{dagger}, Graham R. Leggatt* and Ian H. Frazer*

*Immunology Program, University of Queensland Diamantina Institute for Cancer, Immunology and Metabolic Medicine, Princess Alexandra Hospital, Woolloongabba, Brisbane, Australia; and {dagger}Bone Marrow Transplantation Laboratory, Queensland Institute of Medical Research, Herston, Queensland, Australia

Ags characterizing tumors or chronic viral infection are generally presented to the host immune system before specific immunotherapy is initiated, and consequent generation of regulatory CD4+ T cells can inhibit induction of desired effector CD8 T cell responses. IL-10 produced in response to ongoing Ag exposure inhibits generation of CD8 T cells in an Ag-experienced host. We now show that this IL-10 is produced by Ag experienced CD4+ glucocorticoid-induced tumor necrosis factor receptor+ T cells that also secrete IFN-{gamma} upon antigenic stimulation, that IL-10 secretion by these cells is enhanced through IFN-{gamma} signaling, and, unexpectedly, that IFN-{gamma} signaling is required for inhibition of generation of Ag-specific CD8 T cell responses in an Ag-experienced host. Systemic inhibition of both IL-10 and IFN-{gamma} at the time of immunization may therefore facilitate induction of effective immunotherapeutic responses against tumor specific and viral Ags.

Address correspondence and reprint requests to Prof. Ian Frazer, Diamantina Institute for Cancer, Immunology and Metabolic Medicine, University of Queensland, Princess Alexandra Hospital, Brisbane, Australia. E-mail address: i.frazer{at}uq.edu.au.




This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
J. Chen and X. S. Liu
Development and function of IL-10 IFN-{gamma}-secreting CD4+ T cells
J. Leukoc. Biol., December 1, 2009; 86(6): 1305 - 1310.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. L. Disis
Enhancing Cancer Vaccine Efficacy via Modulation of the Tumor Microenvironment
Clin. Cancer Res., November 1, 2009; 15(21): 6476 - 6478.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.